{"transactions":[{"id":4639273,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-10-13T20:05:20.000Z","date":"2026-10-12","kind":"grant","planned":false,"acquired":true,"shares":3846,"price":5.53,"value":21268.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's common shares were acquired pursuant to the Fennec Pharmaceuticals Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of April 9, 2026 through October 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on the Nasdaq Capital Market on April 9, 2026."}],"balance_after":13533,"source":{"system":"sec-edgar","filing":"0002043395-26-000016","document":"form4-10132026_041010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000016/form4-10132026_041010.xml","form_type":"4"}},{"id":4639275,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-10-13T20:05:17.000Z","date":"2026-10-12","kind":"grant","planned":false,"acquired":true,"shares":2224,"price":5.53,"value":12298.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's common shares were acquired pursuant to the Fennec Pharmaceuticals Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of April 9, 2026 through October 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on the Nasdaq Capital Market on April 9, 2026."}],"balance_after":69685,"source":{"system":"sec-edgar","filing":"0001926254-26-000018","document":"form4-10132026_041008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1926254/000192625426000018/form4-10132026_041008.xml","form_type":"4"}},{"id":4639267,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-10-13T20:05:13.000Z","date":"2026-10-12","kind":"grant","planned":false,"acquired":true,"shares":2326,"price":5.53,"value":12862.78,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's common shares were acquired pursuant to the Fennec Pharmaceuticals Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of April 9, 2026 through October 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on the Nasdaq Capital Market on April 9, 2026."}],"balance_after":24013,"source":{"system":"sec-edgar","filing":"0002043317-26-000016","document":"form4-10132026_041005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000016/form4-10132026_041005.xml","form_type":"4"}},{"id":4639270,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-10-13T20:05:08.000Z","date":"2026-10-12","kind":"grant","planned":false,"acquired":true,"shares":3946,"price":5.53,"value":21821.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's common shares were acquired pursuant to the Fennec Pharmaceuticals Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of April 9, 2026 through October 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on the Nasdaq Capital Market on April 9, 2026."}],"balance_after":28746,"source":{"system":"sec-edgar","filing":"0002043411-26-000018","document":"form4-10132026_041003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000018/form4-10132026_041003.xml","form_type":"4"}},{"id":4639266,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-10-13T20:05:06.000Z","date":"2026-10-12","kind":"grant","planned":false,"acquired":true,"shares":3846,"price":5.53,"value":21268.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's common shares were acquired pursuant to the Fennec Pharmaceuticals Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of April 9, 2026 through October 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on the Nasdaq Capital Market on April 9, 2026."}],"balance_after":246855,"source":{"system":"sec-edgar","filing":"0001468308-26-000034","document":"form4-10132026_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000034/form4-10132026_041001.xml","form_type":"4"}},{"id":4634143,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-10-02T00:05:19.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":9687,"source":{"system":"sec-edgar","filing":"0002043395-26-000014","document":"form4-10012026_041009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000014/form4-10012026_041009.xml","form_type":"4"}},{"id":4634150,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-10-02T00:05:17.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21687,"source":{"system":"sec-edgar","filing":"0002043317-26-000014","document":"form4-10012026_041007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000014/form4-10012026_041007.xml","form_type":"4"}},{"id":4635083,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-10-02T00:05:10.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":67461,"source":{"system":"sec-edgar","filing":"0001926254-26-000016","document":"form4-10012026_041005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000016/form4-10012026_041005.xml","form_type":"4"}},{"id":4634147,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-10-02T00:05:07.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24800,"source":{"system":"sec-edgar","filing":"0002043411-26-000016","document":"form4-10012026_041003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000016/form4-10012026_041003.xml","form_type":"4"}},{"id":4634827,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-10-02T00:05:05.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":243009,"source":{"system":"sec-edgar","filing":"0001468308-26-000032","document":"form4-10012026_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000032/form4-10012026_041001.xml","form_type":"4"}},{"id":4619179,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39611,"kind":"person","name":"Brughera Marco Maria","position":1,"cik":"0001589776","reported_name":"Brughera Marco Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-09-16T20:05:15.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":false,"shares":15545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on June 16, 2026."}],"balance_after":220000,"derivative":{"exercise_price":2.11,"exercise_date":"2016-12-30","expiration_date":"2026-12-30","underlying":"Common shares","underlying_shares":15545},"source":{"system":"sec-edgar","filing":"0001589776-26-000004","document":"form4-09162026_040901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1589776/000158977626000004/form4-09162026_040901.xml","form_type":"4"}},{"id":4619178,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39611,"kind":"person","name":"Brughera Marco Maria","position":1,"cik":"0001589776","reported_name":"Brughera Marco Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-16T20:05:15.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":15545,"price":10.29,"value":159958.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold pursuant to a 10b5-1 plan adopted on June 16, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001589776-26-000004","document":"form4-09162026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1589776/000158977626000004/form4-09162026_040901.xml","form_type":"4"}},{"id":4619177,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39611,"kind":"person","name":"Brughera Marco Maria","position":1,"cik":"0001589776","reported_name":"Brughera Marco Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-16T20:05:15.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":true,"shares":15545,"price":2.11,"value":32799.95,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on June 16, 2026."}],"balance_after":15545,"source":{"system":"sec-edgar","filing":"0001589776-26-000004","document":"form4-09162026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589776/000158977626000004/form4-09162026_040901.xml","form_type":"4"}},{"id":671039,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common shares","published_at":"2026-09-01T20:05:10.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":12.11,"value":121100.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares sold pursuant to a 10b5-1 plan dated September 19, 2025."}],"balance_after":124411,"source":{"system":"sec-edgar","filing":"0001468316-26-000023","document":"form4-09012026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000023/form4-09012026_040901.xml","form_type":"4"}},{"id":671038,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common shares","published_at":"2026-09-01T20:05:10.000Z","date":"2026-08-31","kind":"grant","planned":true,"acquired":true,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024."}],"balance_after":134411,"source":{"system":"sec-edgar","filing":"0001468316-26-000023","document":"form4-09012026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000023/form4-09012026_040901.xml","form_type":"4"}},{"id":672181,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-09-01T00:15:24.000Z","date":"2026-08-31","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":12.18,"value":146160.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents sale of previously vested restricted shares and vested performance shares."}],"balance_after":9519,"source":{"system":"sec-edgar","filing":"0002043395-26-000012","document":"form4-09012026_120920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000012/form4-09012026_120920.xml","form_type":"4"}},{"id":672180,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-09-01T00:15:24.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21519,"source":{"system":"sec-edgar","filing":"0002043395-26-000012","document":"form4-09012026_120920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000012/form4-09012026_120920.xml","form_type":"4"}},{"id":672179,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-09-01T00:13:52.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21519,"source":{"system":"sec-edgar","filing":"0002043317-26-000012","document":"form4-09012026_120948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000012/form4-09012026_120948.xml","form_type":"4"}},{"id":672178,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-09-01T00:12:29.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24644,"source":{"system":"sec-edgar","filing":"0002043411-26-000014","document":"form4-09012026_120925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000014/form4-09012026_120925.xml","form_type":"4"}},{"id":671915,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-09-01T00:10:33.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":66302,"source":{"system":"sec-edgar","filing":"0001926254-26-000014","document":"form4-09012026_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000014/form4-09012026_120929.xml","form_type":"4"}},{"id":671955,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-09-01T00:09:14.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":241306,"source":{"system":"sec-edgar","filing":"0001468308-26-000030","document":"form4-09012026_120910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000030/form4-09012026_120910.xml","form_type":"4"}},{"id":672926,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-08-28T21:42:18.000Z","date":"2026-08-28","kind":"exercise","planned":true,"acquired":false,"shares":21928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option contract with exercise price of $5.10 and an expiration date of June 27, 2027."}],"balance_after":779330,"derivative":{"exercise_price":5.1,"exercise_date":"2017-06-27","expiration_date":"2027-06-27","underlying":"Common Shares","underlying_shares":21928},"source":{"system":"sec-edgar","filing":"0001468308-26-000028","document":"form4-08282026_090813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000028/form4-08282026_090813.xml","form_type":"4"}},{"id":672925,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-08-28T21:42:18.000Z","date":"2026-08-28","kind":"exercise","planned":true,"acquired":true,"shares":21928,"price":5.1,"value":111832.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option contract with exercise price of $5.10 and an expiration date of June 27, 2027."}],"balance_after":239603,"source":{"system":"sec-edgar","filing":"0001468308-26-000028","document":"form4-08282026_090813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000028/form4-08282026_090813.xml","form_type":"4"}},{"id":672924,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-08-28T21:42:18.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":75000,"price":11.78,"value":883500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2026, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). A portion of the sales proceeds from this transaction will be used by the reporting person to pay tax obligations of the reporting person."}],"balance_after":217675,"source":{"system":"sec-edgar","filing":"0001468308-26-000028","document":"form4-08282026_090813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000028/form4-08282026_090813.xml","form_type":"4"}},{"id":697117,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common shares","published_at":"2026-08-04T20:05:14.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":9.58,"value":95800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 plan dated September 19, 2025."}],"balance_after":131633,"source":{"system":"sec-edgar","filing":"0001468316-26-000021","document":"form4-08042026_040802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000021/form4-08042026_040802.xml","form_type":"4"}},{"id":699082,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-08-03T20:05:18.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21351,"source":{"system":"sec-edgar","filing":"0002043395-26-000010","document":"form4-08032026_040811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000010/form4-08032026_040811.xml","form_type":"4"}},{"id":699081,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-08-03T20:05:15.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21351,"source":{"system":"sec-edgar","filing":"0002043317-26-000010","document":"form4-08032026_040809.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000010/form4-08032026_040809.xml","form_type":"4"}},{"id":699080,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-08-03T20:05:13.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24488,"source":{"system":"sec-edgar","filing":"0002043411-26-000012","document":"form4-08032026_040808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000012/form4-08032026_040808.xml","form_type":"4"}},{"id":698732,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-08-03T20:05:12.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":65143,"source":{"system":"sec-edgar","filing":"0001926254-26-000012","document":"form4-08032026_040806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000012/form4-08032026_040806.xml","form_type":"4"}},{"id":698807,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common shares","published_at":"2026-08-03T20:05:10.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024."}],"balance_after":141633,"source":{"system":"sec-edgar","filing":"0001468316-26-000019","document":"form4-08032026_040804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000019/form4-08032026_040804.xml","form_type":"4"}},{"id":698806,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-08-03T20:05:09.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":292675,"source":{"system":"sec-edgar","filing":"0001468308-26-000026","document":"form4-08032026_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000026/form4-08032026_040801.xml","form_type":"4"}},{"id":717824,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Stock Options","published_at":"2026-07-02T20:05:14.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":15597,"price":2.45,"value":38212.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":1525000,"derivative":{"exercise_price":2.45,"exercise_date":"2016-07-05","expiration_date":"2026-07-05","underlying":"options","underlying_shares":15597},"source":{"system":"sec-edgar","filing":"0001468316-26-000017","document":"form4-07022026_040710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000017/form4-07022026_040710.xml","form_type":"4"}},{"id":717823,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common shares","published_at":"2026-07-02T20:05:14.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":9599,"price":10.41,"value":99925.59,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":138855,"source":{"system":"sec-edgar","filing":"0001468316-26-000017","document":"form4-07022026_040710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000017/form4-07022026_040710.xml","form_type":"4"}},{"id":717822,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common shares","published_at":"2026-07-02T20:05:14.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":15597,"price":2.45,"value":38212.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":148454,"source":{"system":"sec-edgar","filing":"0001468316-26-000017","document":"form4-07022026_040710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000017/form4-07022026_040710.xml","form_type":"4"}},{"id":717821,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Common shares","published_at":"2026-07-02T20:05:14.000Z","date":"2026-07-01","kind":"grant","planned":true,"acquired":true,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024."}],"balance_after":132857,"source":{"system":"sec-edgar","filing":"0001468316-26-000017","document":"form4-07022026_040710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000017/form4-07022026_040710.xml","form_type":"4"}},{"id":721591,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-07-01T20:38:58.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21183,"source":{"system":"sec-edgar","filing":"0002043317-26-000008","document":"form4-07012026_080754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000008/form4-07012026_080754.xml","form_type":"4"}},{"id":721593,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-07-01T20:37:26.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21183,"source":{"system":"sec-edgar","filing":"0002043395-26-000008","document":"form4-07012026_080722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000008/form4-07012026_080722.xml","form_type":"4"}},{"id":720873,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-07-01T20:36:17.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":63984,"source":{"system":"sec-edgar","filing":"0001926254-26-000010","document":"form4-07012026_080713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000010/form4-07012026_080713.xml","form_type":"4"}},{"id":721103,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-07-01T20:35:15.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":290972,"source":{"system":"sec-edgar","filing":"0001468308-26-000024","document":"form4-07012026_080710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000024/form4-07012026_080710.xml","form_type":"4"}},{"id":721592,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-07-01T20:34:01.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24332,"source":{"system":"sec-edgar","filing":"0002043411-26-000010","document":"form4-07012026_080757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000010/form4-07012026_080757.xml","form_type":"4"}},{"id":742902,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39611,"kind":"person","name":"Brughera Marco Maria","position":1,"cik":"0001589776","reported_name":"Brughera Marco Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-10T21:50:38.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":8.7,"value":174000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 10, 2026, Marco Brughera was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on date of grant."}],"balance_after":235545,"derivative":{"exercise_price":8.7,"exercise_date":"2026-06-10","expiration_date":"2036-06-10","underlying":"Common shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001589776-26-000002","document":"form4-06102026_090632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000158977626000002/form4-06102026_090632.xml","form_type":"4"}},{"id":742901,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39610,"kind":"person","name":"Cook Jodi A","position":1,"cik":"0001791004","reported_name":"Cook Jodi A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-06-10T21:27:37.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":8.7,"value":174000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 10, 2026, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on date of grant."}],"balance_after":160000,"derivative":{"exercise_price":8.7,"exercise_date":"2026-06-10","expiration_date":"2036-06-10","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001791004-26-000002","document":"form4-06102026_090632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000179100426000002/form4-06102026_090632.xml","form_type":"4"}},{"id":743184,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-10T21:26:36.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":8.7,"value":217500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 10, 2026, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on date of grant."}],"balance_after":250000,"derivative":{"exercise_price":8.7,"exercise_date":"2026-06-10","expiration_date":"2036-06-10","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001701858-26-000002","document":"form4-06102026_090631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701858/000170185826000002/form4-06102026_090631.xml","form_type":"4"}},{"id":742911,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-10T21:24:49.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":8.7,"value":174000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 10, 2026, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is 100% vested on date of grant."}],"balance_after":200000,"derivative":{"exercise_price":8.7,"exercise_date":"2026-06-10","expiration_date":"2036-06-10","underlying":"Common shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001185945-26-000004","document":"form4-06102026_090645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594526000004/form4-06102026_090645.xml","form_type":"4"}},{"id":754638,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-06-02T20:05:28.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":false,"shares":15597,"price":2.45,"value":38212.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":1556195,"derivative":{"exercise_price":2.45,"exercise_date":"2016-07-05","expiration_date":"2026-07-05","underlying":"options","underlying_shares":15597},"source":{"system":"sec-edgar","filing":"0001468316-26-000015","document":"form4-06022026_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000015/form4-06022026_040601.xml","form_type":"4"}},{"id":754637,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-06-02T20:05:28.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":9747,"price":9.62,"value":93766.14,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":130079,"source":{"system":"sec-edgar","filing":"0001468316-26-000015","document":"form4-06022026_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000015/form4-06022026_040601.xml","form_type":"4"}},{"id":754636,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-06-02T20:05:28.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":true,"shares":15597,"price":2.45,"value":38212.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":139826,"source":{"system":"sec-edgar","filing":"0001468316-26-000015","document":"form4-06022026_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000015/form4-06022026_040601.xml","form_type":"4"}},{"id":754635,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-06-02T20:05:28.000Z","date":"2026-05-31","kind":"grant","planned":true,"acquired":true,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024."}],"balance_after":124229,"source":{"system":"sec-edgar","filing":"0001468316-26-000015","document":"form4-06022026_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000015/form4-06022026_040601.xml","form_type":"4"}},{"id":757395,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-06-01T20:05:19.000Z","date":"2026-05-31","kind":"grant","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24176,"source":{"system":"sec-edgar","filing":"0002043411-26-000008","document":"form4-06012026_040609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000008/form4-06012026_040609.xml","form_type":"4"}},{"id":757394,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-06-01T20:05:17.000Z","date":"2026-05-31","kind":"grant","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21015,"source":{"system":"sec-edgar","filing":"0002043317-26-000006","document":"form4-06012026_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000006/form4-06012026_040607.xml","form_type":"4"}},{"id":757396,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-06-01T20:05:10.000Z","date":"2026-05-31","kind":"grant","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21015,"source":{"system":"sec-edgar","filing":"0002043395-26-000006","document":"form4-06012026_040605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000006/form4-06012026_040605.xml","form_type":"4"}},{"id":756822,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-06-01T20:05:07.000Z","date":"2026-05-31","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":62825,"source":{"system":"sec-edgar","filing":"0001926254-26-000008","document":"form4-06012026_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000008/form4-06012026_040603.xml","form_type":"4"}},{"id":756958,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-06-01T20:05:06.000Z","date":"2026-05-31","kind":"grant","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":289269,"source":{"system":"sec-edgar","filing":"0001468308-26-000022","document":"form4-06012026_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000022/form4-06012026_040601.xml","form_type":"4"}},{"id":782169,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-12T20:05:17.000Z","date":"2026-05-11","kind":"exercise","planned":true,"acquired":false,"shares":14344,"price":2.44,"value":34999.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on May 19, 2025."}],"balance_after":186189,"derivative":{"exercise_price":2.44,"exercise_date":"2016-06-09","expiration_date":"2026-06-09","underlying":"Common shares","underlying_shares":14344},"source":{"system":"sec-edgar","filing":"0001185945-26-000002","document":"form4-05122026_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594526000002/form4-05122026_040501.xml","form_type":"4"}},{"id":782168,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-12T20:05:17.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":8346,"price":7.04,"value":58755.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":63077,"source":{"system":"sec-edgar","filing":"0001185945-26-000002","document":"form4-05122026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594526000002/form4-05122026_040501.xml","form_type":"4"}},{"id":782167,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":39616,"kind":"person","name":"RALLIS CHRIS A","position":1,"cik":"0001185945","reported_name":"RALLIS CHRIS A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-12T20:05:17.000Z","date":"2026-05-11","kind":"exercise","planned":true,"acquired":true,"shares":14344,"price":2.44,"value":34999.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on May 19, 2025."}],"balance_after":71423,"source":{"system":"sec-edgar","filing":"0001185945-26-000002","document":"form4-05122026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185945/000118594526000002/form4-05122026_040501.xml","form_type":"4"}},{"id":795573,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-05-01T21:00:26.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":false,"shares":15598,"price":2.45,"value":38215.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":1571792,"derivative":{"exercise_price":2.45,"exercise_date":"2016-07-05","expiration_date":"2026-07-05","underlying":"options","underlying_shares":15598},"source":{"system":"sec-edgar","filing":"0001468316-26-000013","document":"form4-05012026_090522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000013/form4-05012026_090522.xml","form_type":"4"}},{"id":795572,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-05-01T21:00:26.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":10781,"price":6.47,"value":69753.07,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":121451,"source":{"system":"sec-edgar","filing":"0001468316-26-000013","document":"form4-05012026_090522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000013/form4-05012026_090522.xml","form_type":"4"}},{"id":795571,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-05-01T21:00:26.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":true,"shares":15598,"price":2.45,"value":38215.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":132232,"source":{"system":"sec-edgar","filing":"0001468316-26-000013","document":"form4-05012026_090522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000013/form4-05012026_090522.xml","form_type":"4"}},{"id":795570,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-05-01T21:00:26.000Z","date":"2026-04-30","kind":"exercise","planned":true,"acquired":true,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024."}],"balance_after":116634,"source":{"system":"sec-edgar","filing":"0001468316-26-000013","document":"form4-05012026_090522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000013/form4-05012026_090522.xml","form_type":"4"}},{"id":795927,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-05-01T20:05:20.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":20847,"source":{"system":"sec-edgar","filing":"0002043317-26-000004","document":"form4-05012026_040507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000004/form4-05012026_040507.xml","form_type":"4"}},{"id":795926,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-05-01T20:05:18.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24020,"source":{"system":"sec-edgar","filing":"0002043411-26-000006","document":"form4-05012026_040505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000006/form4-05012026_040505.xml","form_type":"4"}},{"id":795385,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-05-01T20:05:17.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":61666,"source":{"system":"sec-edgar","filing":"0001926254-26-000006","document":"form4-05012026_040503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000006/form4-05012026_040503.xml","form_type":"4"}},{"id":795574,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-05-01T20:05:15.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":1703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025."}],"balance_after":287566,"source":{"system":"sec-edgar","filing":"0001468308-26-000020","document":"form4-05012026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000020/form4-05012026_040501.xml","form_type":"4"}},{"id":795929,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-05-01T20:05:13.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":20847,"source":{"system":"sec-edgar","filing":"0002043395-26-000004","document":"form4-05012026_040509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000004/form4-05012026_040509.xml","form_type":"4"}},{"id":820358,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Options","published_at":"2026-04-02T20:05:27.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":5.77,"value":692400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this option may be exercised as of March 31, 2027 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":265300,"derivative":{"exercise_price":5.77,"exercise_date":"2027-03-31","expiration_date":"2036-03-31","underlying":"Common Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0002043411-26-000004","document":"form4-04022026_040407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000004/form4-04022026_040407.xml","form_type":"4"}},{"id":820357,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-04-02T20:05:27.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":true,"shares":1901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":23865,"source":{"system":"sec-edgar","filing":"0002043411-26-000004","document":"form4-04022026_040407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000004/form4-04022026_040407.xml","form_type":"4"}},{"id":820356,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-04-02T20:05:27.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21964,"source":{"system":"sec-edgar","filing":"0002043411-26-000004","document":"form4-04022026_040407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000004/form4-04022026_040407.xml","form_type":"4"}},{"id":820355,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-04-02T20:05:27.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":17106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents settlement of PSUs that vested on March 31, 2026."}],"balance_after":21806,"source":{"system":"sec-edgar","filing":"0002043411-26-000004","document":"form4-04022026_040407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000004/form4-04022026_040407.xml","form_type":"4"}},{"id":819169,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2026-04-02T20:05:26.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":5.77,"value":1154000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On March 31, 2026, granted incentive stock options to purchase 200,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this option may be exercised as of March 31, 2027 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":725000,"derivative":{"exercise_price":5.77,"exercise_date":"2027-03-31","expiration_date":"2036-03-31","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001926254-26-000004","document":"form4-04022026_040412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000004/form4-04022026_040412.xml","form_type":"4"}},{"id":819168,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-04-02T20:05:26.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":true,"shares":13943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":60507,"source":{"system":"sec-edgar","filing":"0001926254-26-000004","document":"form4-04022026_040412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000004/form4-04022026_040412.xml","form_type":"4"}},{"id":819167,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-04-02T20:05:26.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":46564,"source":{"system":"sec-edgar","filing":"0001926254-26-000004","document":"form4-04022026_040412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000004/form4-04022026_040412.xml","form_type":"4"}},{"id":819166,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-04-02T20:05:26.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":16695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents settlement of PSUs that vested on March 31, 2026."}],"balance_after":45405,"source":{"system":"sec-edgar","filing":"0001926254-26-000004","document":"form4-04022026_040412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000004/form4-04022026_040412.xml","form_type":"4"}},{"id":819424,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-04-02T20:05:24.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":15598,"price":2.45,"value":38215.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":1587390,"derivative":{"exercise_price":2.45,"exercise_date":"2016-07-05","expiration_date":"2026-07-05","underlying":"options","underlying_shares":15598},"source":{"system":"sec-edgar","filing":"0001468316-26-000010","document":"form4-04022026_040403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000010/form4-04022026_040403.xml","form_type":"4"}},{"id":819423,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-04-02T20:05:24.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":10946,"price":6.31,"value":69069.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025.."}],"balance_after":113856,"source":{"system":"sec-edgar","filing":"0001468316-26-000010","document":"form4-04022026_040403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000010/form4-04022026_040403.xml","form_type":"4"}},{"id":819422,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-04-02T20:05:24.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":15598,"price":2.45,"value":38215.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":124802,"source":{"system":"sec-edgar","filing":"0001468316-26-000010","document":"form4-04022026_040403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000010/form4-04022026_040403.xml","form_type":"4"}},{"id":819421,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-04-02T20:05:24.000Z","date":"2026-03-31","kind":"grant","planned":true,"acquired":true,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":109204,"source":{"system":"sec-edgar","filing":"0001468316-26-000010","document":"form4-04022026_040403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000010/form4-04022026_040403.xml","form_type":"4"}},{"id":820366,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2026-04-02T20:05:18.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":5.77,"value":692400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this option may be exercised as of March 31, 2027 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":270000,"derivative":{"exercise_price":5.77,"exercise_date":"2027-03-31","expiration_date":"2036-03-31","underlying":"Common Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0002043395-26-000002","document":"form4-04022026_040411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000002/form4-04022026_040411.xml","form_type":"4"}},{"id":820365,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common shares","published_at":"2026-04-02T20:05:18.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":true,"shares":2052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":20679,"source":{"system":"sec-edgar","filing":"0002043395-26-000002","document":"form4-04022026_040411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000002/form4-04022026_040411.xml","form_type":"4"}},{"id":820364,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common shares","published_at":"2026-04-02T20:05:18.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":18627,"source":{"system":"sec-edgar","filing":"0002043395-26-000002","document":"form4-04022026_040411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000002/form4-04022026_040411.xml","form_type":"4"}},{"id":820363,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18463,"kind":"person","name":"Sayad Pierre Sargis","position":1,"cik":"0002043395","reported_name":"Sayad Pierre Sargis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-04-02T20:05:18.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":18456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents settlement of PSUs that vested on March 31, 2026."}],"balance_after":18456,"source":{"system":"sec-edgar","filing":"0002043395-26-000002","document":"form4-04022026_040411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043395/000204339526000002/form4-04022026_040411.xml","form_type":"4"}},{"id":820362,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":5.77,"value":692400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this option may be exercised as of March 31, 2027 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":270000,"derivative":{"exercise_price":5.77,"exercise_date":"2027-03-31","expiration_date":"2036-03-31","underlying":"Common Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0002043317-26-000002","document":"form4-04022026_040409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000002/form4-04022026_040409.xml","form_type":"4"}},{"id":820361,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common shares","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":true,"shares":2052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":20679,"source":{"system":"sec-edgar","filing":"0002043317-26-000002","document":"form4-04022026_040409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000002/form4-04022026_040409.xml","form_type":"4"}},{"id":820360,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common shares","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":18627,"source":{"system":"sec-edgar","filing":"0002043317-26-000002","document":"form4-04022026_040409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000002/form4-04022026_040409.xml","form_type":"4"}},{"id":820359,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18462,"kind":"person","name":"Evans Terry L","position":1,"cik":"0002043317","reported_name":"Evans Terry L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":18456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents settlement of PSUs that vested on March 31, 2026."}],"balance_after":18456,"source":{"system":"sec-edgar","filing":"0002043317-26-000002","document":"form4-04022026_040409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043317/000204331726000002/form4-04022026_040409.xml","form_type":"4"}},{"id":819420,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":5.77,"value":692400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares subject to this option may be exercised as of March 31, 2027 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":921045,"derivative":{"exercise_price":5.77,"exercise_date":"2027-03-31","expiration_date":"2036-03-31","underlying":"Options","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001468308-26-000018","document":"form4-04022026_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000018/form4-04022026_040401.xml","form_type":"4"}},{"id":819419,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":true,"shares":12270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":285863,"source":{"system":"sec-edgar","filing":"0001468308-26-000018","document":"form4-04022026_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000018/form4-04022026_040401.xml","form_type":"4"}},{"id":819418,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":2213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":273593,"source":{"system":"sec-edgar","filing":"0001468308-26-000018","document":"form4-04022026_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000018/form4-04022026_040401.xml","form_type":"4"}},{"id":819417,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-04-02T20:05:13.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":14724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents settlement of PSUs that vested on March 31, 2026."}],"balance_after":271380,"source":{"system":"sec-edgar","filing":"0001468308-26-000018","document":"form4-04022026_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000018/form4-04022026_040401.xml","form_type":"4"}},{"id":827306,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-03-26T20:30:18.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":13072,"price":5.1,"value":66667.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027."}],"balance_after":801045,"derivative":{"exercise_price":5.1,"exercise_date":"2017-06-27","expiration_date":"2027-06-27","underlying":"Options","underlying_shares":13072},"source":{"system":"sec-edgar","filing":"0001468308-26-000016","document":"form4-03262026_080309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000016/form4-03262026_080309.xml","form_type":"4"}},{"id":827305,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-03-26T20:30:18.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":true,"shares":13072,"price":5.1,"value":66667.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027."}],"balance_after":256656,"source":{"system":"sec-edgar","filing":"0001468308-26-000016","document":"form4-03262026_080309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000016/form4-03262026_080309.xml","form_type":"4"}},{"id":827507,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Options","published_at":"2026-03-26T20:29:07.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":4700,"price":4.23,"value":19881.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $4.23 and an expiration date of November 13, 2034."}],"balance_after":145300,"derivative":{"exercise_price":4.23,"exercise_date":"2025-11-13","expiration_date":"2034-11-13","underlying":"Common Shares","underlying_shares":4700},"source":{"system":"sec-edgar","filing":"0002043411-26-000002","document":"form4-03262026_080303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000002/form4-03262026_080303.xml","form_type":"4"}},{"id":827506,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-03-26T20:29:07.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":true,"shares":4700,"price":4.23,"value":19881.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $4.23 and an expiration date of November 13, 2034."}],"balance_after":4700,"source":{"system":"sec-edgar","filing":"0002043411-26-000002","document":"form4-03262026_080303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000002/form4-03262026_080303.xml","form_type":"4"}},{"id":866696,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common shares","published_at":"2026-03-03T21:05:11.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":243584,"source":{"system":"sec-edgar","filing":"0001468308-26-000014","document":"form4-03032026_040303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000014/form4-03032026_040303.xml","form_type":"4"}},{"id":866700,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-03-03T21:05:04.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":15598,"price":2.45,"value":38215.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":1587390,"derivative":{"exercise_price":2.45,"exercise_date":"2016-07-05","expiration_date":"2026-07-05","underlying":"options","underlying_shares":15598},"source":{"system":"sec-edgar","filing":"0001468316-26-000008","document":"form4-03032026_040301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000008/form4-03032026_040301.xml","form_type":"4"}},{"id":866699,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-03-03T21:05:04.000Z","date":"2026-02-28","kind":"grant","planned":true,"acquired":true,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024."}],"balance_after":109204,"source":{"system":"sec-edgar","filing":"0001468316-26-000008","document":"form4-03032026_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000008/form4-03032026_040301.xml","form_type":"4"}},{"id":866698,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-03-03T21:05:04.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":10079,"price":8.36,"value":84260.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares sold to satisfy tax obligation on option exercise."}],"balance_after":103996,"source":{"system":"sec-edgar","filing":"0001468316-26-000008","document":"form4-03032026_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000008/form4-03032026_040301.xml","form_type":"4"}},{"id":866697,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":17920,"kind":"person","name":"Raykov Rosty","position":1,"cik":"0001468316","reported_name":"Raykov Rosty","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares","published_at":"2026-03-03T21:05:04.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":15598,"price":2.45,"value":38215.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025."}],"balance_after":114075,"source":{"system":"sec-edgar","filing":"0001468316-26-000008","document":"form4-03032026_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468316/000146831626000008/form4-03032026_040301.xml","form_type":"4"}},{"id":892932,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18360,"kind":"person","name":"Hackman Jeffrey S.","position":1,"cik":"0001926254","reported_name":"Hackman Jeffrey S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-02-19T23:44:43.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":13710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents settlement of PSUs that vested on February 18, 2026."}],"balance_after":28710,"source":{"system":"sec-edgar","filing":"0001926254-26-000002","document":"form4-02192026_110240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1211583/000192625426000002/form4-02192026_110240.xml","form_type":"4"}},{"id":893271,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18382,"kind":"person","name":"Andrade Robert","position":1,"cik":"0001468308","reported_name":"Andrade Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options","published_at":"2026-02-19T23:43:44.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":2450,"price":4.08,"value":9996.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $4.08 and an expiration date of December 20, 2031."}],"balance_after":814117,"derivative":{"exercise_price":4.08,"exercise_date":"2021-12-20","expiration_date":"2031-12-20","underlying":"Options","underlying_shares":2450},"source":{"system":"sec-edgar","filing":"0001468308-26-000012","document":"form4-02192026_110240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1468308/000146830826000012/form4-02192026_110240.xml","form_type":"4"}}],"next_cursor":"2026-02-19T23:43:44.000000Z,893271"}